Avenue Therapeutics Inc.
12/31/2025 | Press release | Distributed by Public on 12/31/2025 08:21
Proxy Results (Form 8-K)
| Item 5.07. | Submission of Matters to a Vote of Security Holders. |
On December 30, 2025, Avenue Therapeutics, Inc. (the "Company" or "Avenue") held its 2025 annual meeting of stockholders (the "Annual Meeting") at 10:00 a.m. Eastern Time by means of an online virtual meeting platform. At the 2025 Annual Meeting, the following proposals were approved: (i) the election of six directors to hold office until the 2026 annual meeting of stockholders; and (ii) the ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025. These proposals are described in detail in the definitive proxy statement for the Annual Meeting filed with the Securities and Exchange Commission on December 5, 2025.
As of the November 25, 2025 record date for the determination of the stockholders entitled to notice of, and to vote at, the 2025 Annual Meeting, 3,183,426 shares of Common Stock were outstanding and eligible to vote with an aggregate of 3,183,426 votes and 250,000 shares of the Company's Class A Preferred Stock were outstanding and eligible to vote with an aggregate of 3,500,000 votes, as determined in accordance with Article IV, Section 2.1.2 of the Company's Third Amended and Restated Certificate of Incorporation, as amended.
Proposal 1
The votes with respect to the election of six directors to hold office until the 2026 annual meeting of stockholders were as follows:
| Director | Votes For |
Votes Withheld |
Broker Non-Votes |
|||||||||
| Jay Kranzler, M.D., Ph.D. | 3,861,508 | 106,488 | 0 | |||||||||
| Faith Charles | 3,862,060 | 105,936 | 0 | |||||||||
| Neil Herskowitz | 3,861,974 | 106,022 | 0 | |||||||||
| Alexandra MacLean, M.D. | 3,861,559 | 106,437 | 0 | |||||||||
| Curtis Oltmans | 3,862,009 | 105,987 | 0 | |||||||||
| Lindsay A. Rosenwald, M.D. | 3,861,558 | 106,438 | 0 | |||||||||
Proposal 2
The vote on the proposal to ratify the selection of KPMG LLP as Avenue's independent registered accounting firm for the year ending December 31, 2025 was as follows:
| Total Votes For | Total Votes Against | Abstentions | ||||||
| 3,862,335 | 104,651 | 1,010 | ||||||
Avenue Therapeutics Inc. published this content on December 31, 2025, and is solely responsible for the information contained herein. Distributed via Edgar on December 31, 2025 at 14:21 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]